Study the correlation between HAMP gene polymorphism (582A/G) and beta thalassemia in Kirkuk city
Keywords:
Beta thalassemia, HAMP gene polymorphism, hepecidinAbstract
The current study aimed to Study the correlation between HAMP gene polymorphism (-582A/G) and beta thalassemia. 150 subjects with thalassemia were taken from both Azadi Teaching Hospital and Al Jumhuri Hospital from November 2021 to April 2022. The experimental work was carried out in private laboratories in Kirkuk, Iraq. The volunteers in the current study were divided as follows: 50 healthy volunteers as a control group. 150 thalassemia patients as a second group. The results of Polymorphism of the hepcidin gene (HAMP) in patients with anemia of CKD showed that the AA allele was 68 (68%), the AG allele 21 (21%) and the GG allele was 11 (11%) in 100 patients, in While in the group of healthy people, the percentage of the AA allele was 37 (76%), the percentage of the AG allele was 12 (24%), and the percentage of the GG allele was 1 (2%), and thus the results showed that the A allele is more common in patients with anemia resulting from for chronic kidney disease.
Downloads
References
Rubin, Emanuel.& Howard, M., Reisner. (2009). Essentials of Rubin's
pathology. 5th , chapter (20): 437-438.
Vullo, R.; Modell, B.&Georranganda, E.(1995). What is Thalassemia. 2nd ed.
Thalassemia International Federation TIF. Cyprus.
AL-Awamy, B.H. (2000). Thalassemia syndromes in Saudi Arabia , Saudi
medical Journal ;10: 8-10.
Tan, K.L.; Tan, J.A.; Wong, Y.C.; Wee, Y.C.;Thong,M.K.&Yap,S.F.(2001).A
rapid and cost-effective protocol for molecular characterization of Beta¬
thalassemia in Malaysia. Genet-Test ; 5(l):17-22.
Cario, H.; Stahnke, k .&Kohne, E .(1999). Beta-Thalassemia in Germany.
Klinpediatr ; 211(6): 7-431.
Fakher, Rahimi; Kaeikhaei, Bijan; Akbari& Mohammad Taghi.(2007).
Application of diagnostic methods and molecular diagnosis of
hemoglobin disorders in Khuzestan province of Iron. Indian Journal of
human genetics; (13)1:5-15.
Lorey, L.(2000). Asian immigration and public health in California :
thalassemia in newborns in California . J. pediathematoloncol ; 22(6): 6-
AL-Akawi, MD. PhD, Zeyad J.; Hala, S. Al-Remawi, MD, MRCP;
KhadijehJ.Al-Namarneh, MSc.(2009). The relationship between the type
of mutation in the globin gene and the type and severity of sickle /beta¬
thalassemia disease in Jordanian patients.Saudi Med J ; 30 (7): 967-968.
AL-Assadi, Zuhair Mohammed Ali. Dr.(2007).Molecular Detection of some
Mutations Associated with Beta-Thalassemia in Iraq. Univ, of BaghdadIraq.
Davies, SC. ; Cronin, E.; Gill ,M.; Greengross, P.; Hicman , M.&normand , C.
(2000). Screening for 1 sickle 1 cell disease and thalasaemia: asystematic
review with supplementary research. Health Technol Assesstls-Sourcel;
: 1-99.
NEMETH, E. & GANZ, T. 2009. The role of hepcidin in iron metabolism.
Actahaematologica, 122, 78-86
Michels K, Nemeth E, Ganz T, Mehrad B. Hepcidin and Host Defense against
Infectious Diseases. PLoS Pathogens 2015;1l(8):e1004998
Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron
disorders. Blood 2016;127(23):2809- 2813.
Roth MP, Meynard D, Coppin H. Regulators of hepcidin expression.
Vitamins & Hormones 2019;110:101-129.
Bansal D. Hepcidin and thalassemia. Indian J Pediatrics. 2017;84(10):731-2.
Island ML, Jouanolle AM, Mosser A, Deugnier Y, David V, Brissot P, et al. A
new mutation in the hepcidin promoter impairs its BMP response and
contributes to a severe phenotype in HFE related hemochromatosis.
Haematologica. 2009;94(5):720-4
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M.,
Ganz, T. & Kaplan,J. 2004. Hepcidin regulates cellular iron efflux bybinding to
ferroportin and inducingits internalization,science,306, 2090-2093.
Parajes S, Gonzalez-Quintela A, Campos J, Quinteiro C, Dominguez F, Loidi
L. Genetic study of the hepcidin gene (HAMP) promoter and functional
analysis of the c.-582A> G variant. BMC Genet. 2010;11(1):110
Andreani M, Radio FC, Testi M, De Bernardo C, Troiano M, Majore S, et al.
Association of hepcidin promoter C.-582 A>G variant and iron overload
in thalassemia major. Haematologica. 2009;94(9):1293-6.
Zarghamian, P.; Azarkeivan, A.; Arabkhazaeli, A.; Mardani, A.; Shahabi, M.
Hepcidin gene polymorphisms and iron overload in p-thalassemia major
patients refractory to iron chelating therapy. BMC Med. Genet. 2020, 21,
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
